KIF1B Gene CMT2A1 Genetic Test
Cost: AED 4400.0
Test Name: KIF1B Gene CMT2A1 Genetic Test
Components: NGS Technology
Price: AED 4400.0
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for KIF1B Gene CMT2A1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1B Gene CMT2A1.
Test Details
The KIF1B gene is associated with Charcot-Marie-Tooth disease type 2A1 (CMT2A1), a genetic disorder that affects the peripheral nerves. This condition leads to muscle weakness and wasting, sensory loss, and difficulty with coordination and balance.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. This type of testing can identify variations or mutations in the KIF1B gene that may be associated with CMT2A1. NGS testing is a highly accurate and efficient method for genetic analysis, allowing for the detection of multiple genetic mutations in a single test.
This testing can help diagnose CMT2A1 early on, enabling individuals to receive appropriate treatment and management of their symptoms.
Test Name | KIF1B Gene CMT2A1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KIF1B Gene CMT2A1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1B Gene CMT2A1 |
Test Details |
KIF1B gene is associated with Charcot-Marie-Tooth disease type 2A1 (CMT2A1), which is a genetic disorder that affects the peripheral nerves. This condition leads to muscle weakness and wasting, sensory loss, and difficulty with coordination and balance. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. This type of testing can identify variations or mutations in the KIF1B gene that may be associated with CMT2A1. NGS testing is a highly accurate and efficient method for genetic analysis, allowing for the detection of multiple genetic mutations in a single test. This testing can help diagnose CMT2A1 early on, enabling individuals to receive appropriate treatment and management of their symptoms. |